U.S. Capital Wealth Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-27
Closed -$4.57K 1323
2022
Q4
$4.57K Buy
+27
New +$4.9K ﹤0.01% 1401

Other funds holding RGEN

U.S. Capital Wealth Advisors's RGEN Position: Q1 2023 in Review

U.S. Capital Wealth Advisors sold out of Repligen (RGEN) in Q1 2023, closing a stake of 27 shares — an estimated $4.57K sold.

U.S. Capital Wealth Advisors first reported a position in RGEN in Q4 2022 and held it in 1 quarter. The position peaked at $4.57K in Q4 2022. 446 funds tracked by Wall St. Rank hold RGEN as of Q1 2023.

  • U.S. Capital Wealth Advisors reported no remaining Repligen position as of Q1 2023 after selling out during the quarter.
  • U.S. Capital Wealth Advisors sold 27 Repligen shares in Q1 2023, an estimated $4.57K.
  • U.S. Capital Wealth Advisors first reported a position in Repligen in Q4 2022 and held it in 1 quarter.
  • U.S. Capital Wealth Advisors's Repligen position peaked at $4.57K in Q4 2022.
  • 446 funds tracked by Wall St. Rank held Repligen as of Q1 2023.

Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.